General Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013
05/04/17Keryx Biopharmaceuticals Announces First Quarter 2017 Financial ResultsPrinter Friendly Version
05/01/17Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D PlansPrinter Friendly Version
04/18/17Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on Thursday, May 4, 2017Printer Friendly Version
03/20/17Keryx Announces the Largest Medicare Part D Plan Sponsor Added Auryxia® to its Medicare Part D Plan FormulariesPrinter Friendly Version
03/08/17Keryx Biopharmaceuticals Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Auryxia® (ferric citrate) TabletsPrinter Friendly Version
03/01/17Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsPrinter Friendly Version
02/23/17Keryx Biopharmaceuticals to Webcast its Presentations at Two Investor Conferences in March 2017Printer Friendly Version
02/16/17Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2016 Financial Results on Wednesday, March 1, 2017Printer Friendly Version
02/08/17Keryx Biopharmaceuticals to Webcast its Presentation at RBC Capital Markets' 2017 Global Healthcare Conference on February 22, 2017Printer Friendly Version
01/12/17Keryx Biopharmaceuticals Announces Publication of Auryxia® (ferric citrate) Phase 3 Trial Results for Iron Deficiency Anemia (IDA) in Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) in Journal of the American Society of NephrologyPrinter Friendly Version
01/08/17Keryx Biopharmaceuticals Announces Recent Business Progress and Reviews Corporate Strategy at 35th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version